A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Orciprenaline
Stiripentol
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Stiripentol.
Orciprenaline
Tasimelteon
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Tasimelteon.
Orciprenaline
Vortioxetine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Vortioxetine.
Orciprenaline
Benzoctamine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Benzoctamine.
Orciprenaline
Brotizolam
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Brotizolam.
Orciprenaline
Butriptyline
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Butriptyline.
Orciprenaline
Captodiame
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Captodiame.
Orciprenaline
Beclamide
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Beclamide.
Orciprenaline
Barbexaclone
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Barbexaclone.
Orciprenaline
Cyamemazine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Cyamemazine.
Orciprenaline
Dimetacrine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Dimetacrine.
Orciprenaline
Etifoxine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Etifoxine.
Orciprenaline
Ifenprodil
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Ifenprodil.
Orciprenaline
Amperozide
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Amperozide.
Orciprenaline
Perospirone
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Perospirone.
Orciprenaline
Pomalidomide
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Pomalidomide.
Orciprenaline
Arbaclofen Placarbil
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Arbaclofen Placarbil.
Orciprenaline
Gabapentin enacarbil
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Gabapentin enacarbil.
Orciprenaline
Serotonin
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Serotonin.
Orciprenaline
Lurasidone
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Lurasidone.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3